MAPT and Alzheimer disease: In population studies, a study by Bonomi et al. demonstrated that major neurodegenerative dementias like AD and FTD showed physiological but decreased levels of CSF lactate and bound the reduction of CSF lactates to the progression of tau pathology [20].